Does free fatty acid infusion impair insulin action also through an increase in oxidative stress?

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 12, 1996, Pages 4244-4248

  Paolisso, Giuseppe ^a,c   Gambardella, Antonio ^a   Tagliamonte, Maria Rosaria ^a   Saccomanno, Franco ^a   Salvatore, Teresa ^a   Gualdiero, Pasquale ^a   D'Onofrio, Michele Varricchio Felice ^a   Howard, Barbara V ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Medlantic Research Institute   (United States)

^c Servizio di Astanteria Medica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; GLUTATHIONE; GLUTATHIONE DERIVATIVE; GLUTATHIONE DISULFIDE; INSULIN; INTRALIPID; LIPID HYDROPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; VOLUNTEER;

EID: 0029819955     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.81.12.8954022     Document Type: Article

References (31)

1. Randle PL, Garland PB, Holes CN, Newsholme EA. 1963 The glucose fatty acid cycle, its role in insulin sensitivity and the metabolic disturbances in diabetes mellitus. Lancet. 1:785-789.
2. Randle PJ, Priestman DA, Mistry S, Halsall A. 1994 Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia. 37(Suppl 2):S155-S161.
3. Paolisso G, Tataranni A, Foley JE, Bogardus C, Howard BV, Ravussin E. 1995 High concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia. 38:1213-1217.
4. Unger RH. 1995 Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes. 44:863-870.
5. Paolisso G, Gambardella A, Amato L, et al. 1995 Opposite effects of short and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia. 38:1295-1299.
6. Boden G, Chen X, Rosner J, Barton M. 1995 Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes. 44:1239-1242.
7. Toborek M, Hennig B. 1994 Fatty acid-mediated effects on the glutathione redox cycle in cultured endothelial cells. Am J Clin Nutr. 59:60-65.
8. Paolisso G, D'Amore A, Di Maro G, et al. 1993 Evidence for a relationship between free radicals and insulin action in the elderly. Metabolism. 42:659-663.
9. Paolisso G, D'Amore A, Volpe C, et al. 1994 Evidence for relationship between oxidative stress and insulin action in non-insulin dependent diabetic patients. Metabolism. 43:1426-1429.
10. Paolisso G, Giugliano D. 1996 Oxidative stress and insulin action: is there a relationship? Diabetologia. 39:357-363.
11. Bjorntorp P. 1991 Metabolic implication of body fat distribution Diabetes Care. 14:1132-1143.
12. Giugliano D, Ceriello A, Paolisso G. 1995 Diabetes mellitus, hypertension and cardiovascular disease. Which role for oxidative stress? Metabolism. 44:363-368.
13. Griesmaker A, Kindhauser M, Andert SE, et al. 1995 Enhanced serum levels of thiobarbituric-acid reactive substance in diabetes mellitus. Am J Med. 98:469-475.
14. WHO Study Group. 1985 Diabetes mellitus: report of a WHO study group. Geneva: WHO; 727:9-17.
15. Paolisso G, Di Maro G, Pizza G, et al. 1992 Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and non-insulin dependent diabetics. Am J Physiol. 263:E435-E440.
16. Dole VP, Meinertz HP. 1960 Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem. 235:2595-2599.
17. Yagi K. 1987 Lipid peroxide and human diseases. Chem Phys Lipids. 45:337-351.
18. Paolisso G, Di Maro G, D'Amore A, et al. 1995 Low dose iloprost infusion improves insulin action in aged healthy subjects and NIDDM patients. Diabetes Care. 18:200-205.
19. Bevilacqua S, Buzzigoli G, Bonadonna R, et al. 1990 Operation of Randle's cycle in patients with NIDDM. Diabetes. 39:383-389.
20. Segal KB, Van Loan M, Fitzgerald PI, Hogdon JA, Van Itallie TB. 1988 Lean body mass estimation by bioelectrical impedance analysis: a four site validation study. Am J Clin Nutr. 47:7-14.
21. Hennig B, Chung BH, Watkins BA, Alvarado A. 1992 Disruption of endothelial barrier function by lipolitic remnants of triglyceride-rich lipoproteins. Atherosclerosis. 95:235-247.
22. Cosgrove JP, Church DF, Pryor WA. 1987 The kinetics of the autoxidation of polyunsaturated fatty acids. Lipids. 22:299-304.
23. Hennig B, Enoch C, Chow CK. 1987 Protection by vitamin E against endothelial cell injury linoleic acid hydroperoxides. Nutr Res. 7:1253-1259.
24. Tamura H, Shibamoto T. 1991 Gas chromatographic analysis of malonaldehyde and 4-hydroxy-2-(E)-noneal produced from arachidonic acid and linoleic acid in a lipid peroxidation model system. Lipids. 26:170-173.
25. Natarajan V, Taher MM, Rohem B. 1993 Activation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid hydroperoxide. J Biol Chem. 268:930-937.
26. 77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers. J Cell Physiol. 153:62-75.
27. Rasmasamy S, Boissoneault GA, Decker EA, Hennig B. 1991 Linoleic acid-induced endothelial cell injury:role of membrane-bound enzyme activities and lipid oxidation. J Biochem Toxicol. 6:29-35.
28. Hennig B, Alavarado A, Ramasamy S, Boissoneualt GA, Decker EA, Means WJ. 1990 Fatty acid-induced disruption of endothelial barrier function in culture. Biochem Arch. 6:409-417.
29. Borkman M., Storlien LH, Pan DD, Jenkins AB, Chisholm DJ, Campbel LV. 1993 The relationship between insulin sensitivity and fatty acid composition of skeletal muscle phospholipids. N Engl J Med. 328:238-244.
30. Levy J, Gavin III JR, Sowers JR. 1994 Diabetes mellitus: a diseases of abnormal cellular caclium metabolism. Ann Intern Med. 96:260-273.
31. Ganrot PO. 1993 Insulin resistance:possible key of blood flow in resting muscle. Diabetologia. 36:876-879.